全文获取类型
收费全文 | 37324篇 |
免费 | 3889篇 |
国内免费 | 1572篇 |
专业分类
耳鼻咽喉 | 356篇 |
儿科学 | 677篇 |
妇产科学 | 559篇 |
基础医学 | 3540篇 |
口腔科学 | 719篇 |
临床医学 | 4577篇 |
内科学 | 5330篇 |
皮肤病学 | 618篇 |
神经病学 | 2108篇 |
特种医学 | 1087篇 |
外国民族医学 | 2篇 |
外科学 | 3436篇 |
综合类 | 5882篇 |
现状与发展 | 17篇 |
一般理论 | 25篇 |
预防医学 | 3721篇 |
眼科学 | 1012篇 |
药学 | 4174篇 |
56篇 | |
中国医学 | 2581篇 |
肿瘤学 | 2308篇 |
出版年
2024年 | 495篇 |
2023年 | 555篇 |
2022年 | 1443篇 |
2021年 | 1859篇 |
2020年 | 1531篇 |
2019年 | 1225篇 |
2018年 | 1372篇 |
2017年 | 1352篇 |
2016年 | 1208篇 |
2015年 | 1621篇 |
2014年 | 1933篇 |
2013年 | 2108篇 |
2012年 | 3143篇 |
2011年 | 3214篇 |
2010年 | 2329篇 |
2009年 | 1986篇 |
2008年 | 2467篇 |
2007年 | 2277篇 |
2006年 | 2037篇 |
2005年 | 1840篇 |
2004年 | 1351篇 |
2003年 | 1258篇 |
2002年 | 1031篇 |
2001年 | 396篇 |
2000年 | 351篇 |
1999年 | 233篇 |
1998年 | 262篇 |
1997年 | 192篇 |
1996年 | 138篇 |
1995年 | 125篇 |
1994年 | 127篇 |
1993年 | 89篇 |
1992年 | 114篇 |
1991年 | 108篇 |
1990年 | 93篇 |
1989年 | 68篇 |
1988年 | 61篇 |
1987年 | 62篇 |
1986年 | 76篇 |
1985年 | 58篇 |
1984年 | 61篇 |
1983年 | 70篇 |
1982年 | 74篇 |
1981年 | 48篇 |
1980年 | 40篇 |
1979年 | 34篇 |
1978年 | 34篇 |
1977年 | 33篇 |
1974年 | 22篇 |
1973年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
Huabin Yin MD Wang Zhou MD Jia Meng MD Dan Zhang MD Zhipeng Wu MD Ting Wang MD Jing Wang MD Peng Wang MD Xin Shi MD Sujia Wu MD Jianning Zhao MD Jianru Xiao MD 《Annals of surgical oncology》2014,21(11):3572-3578
Purpose
Chondrosarcoma (CHS) in the spine is relatively rare and minimal information has been published in the literature regarding this subject. The objective of our study was to discuss the factors that may affect outcomes of patients with spinal CHS.Methods
Univariate and multivariate analyses were performed to identify prognostic factors for recurrence, distant metastasis, and survival of spinal CHS. T test, χ 2 test and rank sum test were used to analyze a single factor for recurrence and metastasis, while survival rate was estimated using the Kaplan–Meier method. Factors with p values of ≤0.1 were subjected to multivariate analyses by binary logistic regression analyses or Cox regression analyses. p Values of ≤0.05 were considered statistically significant.Results
A total of 98 patients with spinal CHS were included in the study. The mean follow-up period was 49.7 months (range 6–178). Recurrence was detected in 42 patients after initial surgery in our center, while distant metastasis and death occurred in 24 and 32 cases, respectively. The statistical analyses suggested that pathology grade III was closely related with distant metastasis which was an independent prognostic factor for overall survival. Total en bloc spondylectomy could significantly decrease the risk of recurrence, distant metastasis, and death of patients with spinal CHS.Conclusions
Total en bloc spondylectomy could significantly decrease the risk of recurrence and distant metastasis, and meanwhile improve overall survival of spinal CHS. Distant metastasis which was closely associated with pathology grade III was an adverse prognostic factor for overall survival of spinal CHS. 相似文献42.
Joshua Quaas Bruce Derrick Lindsey Mitrani Simon Baarbe Brett Yarusi Dan Wiener David Newman 《Injury》2014
Objective
Assess factors that influence both the patient and the physician in the setting of minor head injury in adults and the decision-making process around CT utilization.Methods
This is a convenience sample survey study of adult minor head injury patients (GCS 15) and their physicians regarding factors influencing the decision to use CT to evaluate for intra-cranial haemorrhage. Once a head CT was ordered and before the results were known, both the patient and physician were given a one-page survey asking questions about their concern for injury and rationale for CT use. CT results and surveys were then recorded in a centralized database and analyzed.Results
584 subjects were enrolled over the 27-month study period. The rate of any intra-cranial haemorrhage was 3.3%. Both the physicians (6% pre-test estimate) and the patients (22% pre-test estimate) over-estimated risk for haemorrhage. Clinical decision rules were not met in 46% of cases where CT was used. Physicians listed an average of 5 factors from a list of 9 that influenced their decision to order CT. Patients listed an average of 1.7 factors influencing their decision to present to the Emergency Department for evaluation. Many patients felt cost (45%) and low risk stratification (34%) should weigh heavily in the decision to use CT. If asked to limit CT utilization, physicians were able to identify a group with less than 2% risk of injury.Conclusions
Patients with low risk of intra-cranial injury continue to be evaluated by CT. Physician decision-making around the use of CT to evaluate minor head injury is multi-factorial. Shared decision-making between the patient and the physician in a low risk minor head injury encounter shows promise as a method to reduce CT utilization in this low risk cohort. 相似文献43.
Background/purpose
NSQIP Pediatric (NSQIP-P) is a robust quality improvement effort. A limitation of the NSQIP process lies in capturing a small proportion of the total case volume. This study examines whether appendectomies captured by NSQIP-P are concordant with all appendectomies, the most commonly captured procedure in 2011.Methods
We compared case mix and 30-day outcomes between children undergoing an appendectomy who were included in NSQIP (n = 80) and children not captured by NSQIP (n = 276) during 2011 at a tertiary referral children’s hospital. A single surgical case reviewer reviewed all cases using NSQIP-P methodology.Results
NSQIP-P captured 80 of a total of 356 appendectomies (22%). The case mix was similar between NSQIP and non-NSQIP groups (e.g., 31% of each group had complicated appendicitis). Outcomes were also similar; post-operative occurrences, readmissions and return to the operation room occurred at rates of 7.5% vs. 7.6%, 5% vs. 4.7%, and 3.8% vs. 4.3% respectively.Conclusion
Although NSQIP-P captured a minority of the total patient population that had an appendectomy, the case mix and outcomes were similar. Our results offer reassurance that NSQIP-P data are representative of the larger population for this procedure. Whether this concordance exists for procedures less commonly performed is unknown and a focus of ongoing work. 相似文献44.
45.
46.
47.
48.
Mubeen Khan MD Mrinalini Balki MD Iram Ahmed MD Dan Farine MD Gareth Seaward MD Jose C. A. Carvalho MD PhD 《Journal canadien d'anesthésie》2014,61(3):242-248
Purpose
The purpose of this study was to determine the intravenous dose of carbetocin required to produce effective uterine contraction in 90% of females (ED90) undergoing elective Cesarean delivery (CD) under spinal anesthesia.Methods
We conducted a double-blind dose-finding study of carbetocin. Forty females undergoing elective CD received carbetocin intravenously upon delivery of the fetus. The dose of carbetocin for each patient was determined according to a biased-coin up-and-down sequential allocation scheme designed to cluster doses close to ED90. The initial dose was 10 μg, with increments/decrements of 5 μg. The anesthesiologist, obstetrician, and patient were blinded to the dose. The obstetrician assessed the uterine tone at one-minute intervals for five minutes after carbetocin administration. In case of unsatisfactory tone, additional uterotonics were administered. The primary outcome was requirement for additional intraoperative uterotonics. Secondary outcomes were postoperative requirement for additional uterotonics within 24 hr of delivery, estimated blood loss and side effects.Results
The ED90 of carbetocin was 14.8 μg (95% confidence interval 13.7 to 15.8). Thirty-seven patients (92.5%) had adequate uterine tone with no requirement of additional intraoperative uterotonics. Two patients (5%) required postoperative uterotonics within 24 hr. The overall mean (SD) estimated blood loss was 786 (403) mL and the overall incidence of hypotension (decrease in systolic blood pressure ≥ 20% baseline) was 37.5%.Conclusion
Based on our study, the ED90 of carbetocin at elective CD is less than one-fifth the currently recommended dose of 100 μg. This study was registered at clinicaltrials.gov (NCT-01651130). 相似文献49.
50.